Our aim is to revolutionize care for people and planet. We drive change that improves the health and wellbeing of patients and those who care for them – while reducing the environmental footprint of healthcare and the life sciences.
Sterile, blue cleanroom undergloves with beaded cuffs and curved fingers are made to be worn in combination with the Biogel™ NeoTech overglove to form a breach indication system. The gloves are suitable for use in aseptic and Class 100 (ISO 5) / EU GMP Grade A environments.
Sterile, cleanroom gloves with beaded anti-slip cuffs and curved fingers are suitable for use in aseptic and Class 100 (ISO 5) / EU GMP Grade A environments. Adviced to be worn in combination with the Biogel™ PI Tech Indicator Underglove to form a breach indication system.
Sterile, blue cleanroom undergloves with beaded cuffs and curved fingers are made to be worn in combination with the Biogel™ PI Tech overglove to form a breach indication system. The gloves are suitable for use in aseptic and Class 100 (ISO 5) / EU GMP Grade A environments.
Sterile, cleanroom gloves with beaded anti-slip cuffs and curved fingers are suitable for use in aseptic and Class 100 (ISO 5) / EU GMP Grade A environments. Adviced to be worn in combination with the Biogel™ PI Micro Tech Indicator Underglove to form a breach indication system.
Sterile, blue cleanroom undergloves with beaded cuffs and curved fingers are made to be worn in combination with the Biogel™ PI Micro Tech overglove to form a breach indication system. The gloves are suitable for use in aseptic and Class 100 (ISO 5) / EU GMP Grade A environments.
Sterile cleanroom gloves with beaded cuffs and curved fingers are suitable for use in aseptic and Class 100 (ISO 5) / EU GMP Grade A environments. Adviced to be worn in combination with the Biogel™ NeoTech Indicator™ Underglove to form a breach indication system.
Sterile durable all-purpose critical environment glove. It offers excellent barrier protection as well as fit, feel and comfort . It has been tested and cleared for use with chemotherapy agents.
La innovación está en el centro de lo que somos como empresa. Mölnlycke ha estado a la vanguardia del cambio desde 1849, siendo pionera en innovaciones que mejoran la calidad de vida de los pacientes y de quienes los cuidan, al tiempo que reducen el impacto medioambiental de la asistencia sanitaria y las ciencias de la vida. Nos asociamos con quienes buscan dar forma al futuro de la asistencia, no sólo para resolver los problemas de hoy, sino también para afrontar los retos del mañana. En el futuro nos basaremos en nuestro orgulloso legado para seguir revolucionando la atención a las personas y el planeta.
Mölnlycke emplea a más de 8.000 personas. La sede central de la empresa está en Gotemburgo (Suecia) y operamos en más de 100 países de todo el mundo. Desde 2007, la empresa forma parte de Investor AB, un propietario comprometido de empresas globales de alta calidad fundado por la familia Wallenberg en 1916.
